Optimizing Tissue Clearing Methods for Improved Imaging of Whole-Mount Retinas

preprint OA: closed
📄 Open PDF Full text JSON View at publisher

Abstract

Gene and cell therapies are promising approaches for restoring vision in hereditary and advanced optic neuropathies. However, these therapeutic approaches must be accurately evaluated through a combination of methods, including advanced imaging, to reach the clinic. We present a whole-mount tissue-clearing methodology to improve imaging of donor neuron integration in the retina following cell transplantation in mice. Mouse retinas were processed using five different clearing methods, comparing tissue transparency, pigmentation, and immunohistochemical clarity. Among the tested methods, ScaleS consistently outperformed its peers, demonstrating a 46% increase in tissue transparency and an 89% increase in immunohistochemical clarity compared to controls. We developed a modified version of ScaleS, termed ScaleH, by adding polyvinyl alcohol to reduce fluorescence decay and enhance sample stability. ScaleH maintained fluorescence stability over extended periods (32% less decay) and proved compatible with immunolabeling and endogenous fluorescent reporters, enabling improved visualization of transplanted human stem cell-derived retinal neurons in the mouse retina. Moreover, ScaleH also improved optic nerve imaging, demonstrating the potential for broader neurobiological applications. Our clearing workflow supports robust, high-resolution imaging for evaluating the integration of transplanted cells in regenerative studies.
Full text 1,575 characters · extracted from oa-doi-fallback · click to expand
Abstract Gene and cell therapies are promising approaches for restoring vision in hereditary and advanced optic neuropathies. However, these therapeutic approaches must be accurately evaluated through a combination of methods, including advanced imaging, to reach the clinic. We present a whole-mount tissue-clearing methodology to improve imaging of donor neuron integration in the retina following cell transplantation in mice. Mouse retinas were processed using five different clearing methods, comparing tissue transparency, pigmentation, and immunohistochemical clarity. Among the tested methods, ScaleS consistently outperformed its peers, demonstrating a 46% increase in tissue transparency and an 89% increase in immunohistochemical clarity compared to controls. We developed a modified version of ScaleS, termed ScaleH, by adding polyvinyl alcohol to reduce fluorescence decay and enhance sample stability. ScaleH maintained fluorescence stability over extended periods (32% less decay) and proved compatible with immunolabeling and endogenous fluorescent reporters, enabling improved visualization of transplanted human stem cell-derived retinal neurons in the mouse retina. Moreover, ScaleH also improved optic nerve imaging, demonstrating the potential for broader neurobiological applications. Our clearing workflow supports robust, high-resolution imaging for evaluating the integration of transplanted cells in regenerative studies. Competing Interest Statement The authors have declared no competing interest. Footnotes Updated the figures and text throughout

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00